Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell-Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01729689
What this trial is testing

Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers

Who this might be right for
Anxiety DisorderRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Stanford University 13
Early research (Phase 1)Ended earlyNCT04795713
What this trial is testing

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck
Molecular Templates, Inc. 64
Large-scale testing (Phase 3)Study completedNCT00002623
What this trial is testing

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 640
Testing effectiveness (Phase 2)Study completedNCT00826449
What this trial is testing

Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
M.D. Anderson Cancer Center 53
Not applicableStudy completedNCT01597258
What this trial is testing

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 2,029
Not applicableStudy completedNCT05380908
What this trial is testing

Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small-cell Lung Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 90
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Testing effectiveness (Phase 2)UnknownNCT02069418
What this trial is testing

Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient

Who this might be right for
Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer RecurrentNo EGFR Activating Mutation
University Hospital, Angers 80
Large-scale testing (Phase 3)Study completedNCT00440414
What this trial is testing

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 320
Large-scale testing (Phase 3)Study completedNCT00035152
What this trial is testing

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 444
Not applicableStudy completedNCT00641238
What this trial is testing

Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
State University of New York - Upstate Medical University 20
Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Not applicableStudy completedNCT00089310
What this trial is testing

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Study completedNCT00630110
What this trial is testing

Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Cancer
Nereus Pharmaceuticals, Inc. 172
Large-scale testing (Phase 3)UnknownNCT06031597
What this trial is testing

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage III
Zhejiang Cancer Hospital 105
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Not applicableStudy completedNCT01182155
What this trial is testing

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

Who this might be right for
Lung CancerNon-Small Cell Lung CancerSmall Cell Lung Cancer
Stanford University 20
Early research (Phase 1)Study completedNCT00028535
What this trial is testing

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial Carcinoma+4 more
National Cancer Institute (NCI) 18
Post-approval studies (Phase 4)UnknownNCT04356118
What this trial is testing

Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal Metastasis
Hui Bu 30
Post-approval studies (Phase 4)UnknownNCT01336192
What this trial is testing

Maintenance Gemcitabine in the Chinese Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Tongji University 240
Next Page